Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Dermatology

RSS  

Articles

  • Pharmacology Update: Icosapent Ethyl Capsules (Vascepa™)

    The FDA has approved an ethyl ester of eicosapentaenoic acid (EPA) to treat hypertriglyceridemia. It is the second drug in this class after Lovaza, which contains esters of both EPA and DHA (docosahexaenoic acid). Icosapent ethyl is marketed by Amarin Pharmaceuticals, a Dublin, Ireland-based company, as Vascepa.
  • ECG Review: Flutter or the Patient?

    Scenario: The lead II rhythm strip shown above was observed on telemetry. Is the patient in atrial flutter?
  • Clinical Briefs By Louis Kuritzky, MD

    Quality-of-life Effects of PSA Screening; Secondary Prevention of Lacunar Stroke; PSA Elevations After Prostate Cancer Radiotherapy
  • What HbA1c for the Very Elderly?

    In a nursing home-eligible population with a mean age of 80, those with a HbA1c between 8% and 8.9% had less functional decline than those with a HbA1c of 7% to 7.9%.
  • Spiritual Assessment in Primary Care

    Evidence-based spiritual assessment tools are presented in this manuscript, which open a dialogue between patients and physicians. These adjunctive therapeutic interventions have been found to improve outcomes for patients with depression, cardiovascular disease, pain, anxiety, and adolescent risk behaviors.
  • Pharmacology Watch: Statins and Cognition — More to the Story?

    Side effects of statins; effects of cannabis use; antihypertensives and lip cancer; and FDA actions.
  • Sexually Transmitted Diseases

    Sexually transmitted diseases (STDs) are frequently encountered in clinical medicine. According to the Centers for Disease Control, approximately 2.8 million infections with Chlamydia trachomatis1 and 700,000 infections with Neisseria gonorrhea2 occur annually in the United States. Viral sexually transmitted diseases are frequently incurable, so prevalence data are a better measure of the overall burden of disease.
  • Eyeing Another Risk from Bisphosphonates

    People using oral bisphosphonates for the first time may be at a higher risk of developing ocular inflammatory adverse events such as scleritis and uveitis.
  • Cardiovascular Dangers of Long-Term Endurance Exercise

    While regular exercise is beneficial to overall health, repeated long-term endurance exercise — such as marathons, ultramarathons, ironman triathlons, and long-distance bicycle racing — may cause myocardial scarring and increase the risk of serious arrythmias, coronary artery calcification, diastolic dysfunction, and large-artery wall stiffening.
  • Clinical Briefs

    Clinical Briefs: Another Look at Bleeding Risk from Aspirin; Can Aspirin Prevent Recurrence of Thromboembolism?; A New Approach to Tinnitus